Transforming growth factor-beta in the brain enhances fat oxidation via noradrenergic neurons in the ventromedial and paraventricular hypothalamic nucleus

Brain Research

Volumn 1173, Issue 1, 2007, Pages 92-101

  Fujikawa, Teppei ^a   Matsumura, Shigenobu ^a   Yamada, Hiroyuki ^a   Inoue, Kazuo ^a   Fushiki, Tohru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Energy metabolism; Fat oxidation; Hypothalamus; Microdialysis; Noradrenergic neuron; Transforming growth factor beta

Indexed keywords

FAT; FATTY ACID; GLUCOSE; KETONE; NEUROTOXIN; NORADRENALIN; OXIDOPAMINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; BRAIN DAMAGE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG EFFECT; ENERGY METABOLISM; HYPOTHALAMUS; LUNG GAS EXCHANGE; MICRODIALYSIS; NEUROTOXICITY; NONHUMAN; NORADRENERGIC NERVE; OXIDATION; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; BRAIN CHEMISTRY; ENERGY METABOLISM; FATS; MALE; MICRODIALYSIS; NEURONS; NOREPINEPHRINE; OXIDATION-REDUCTION; OXIDOPAMINE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA3; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

RATTUS;

EID: 34548818507     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.08.002     Document Type: Article

References (43)

1. Ahlskog J.E., Randall P.K., and Hoebel B.G. Hupothalamic hyperphagia: dissociation from hyperphagia following destruction of noradrenergic neurons. Science 190 (1975) 399-401
2. Arai M., Yamazaki H., Inoue K., and Fushiki T. Effects of intracranial injection of transforming growth factor-beta relevant to central fatigue on the waking electroencephalogram of rats: comparison with effects of exercise. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26 (2002) 307-312
3. Bamshad M., Song C.K., and Bartness T.J. CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am. J. Physiol. 276 (1999) R1569-R1578
4. Binzen C.A., Swan P.D., and Manore M.M. Postexercise oxygen consumption and substrate use after resistance exercise in women. Med. Sci. Sports Exerc. 33 (2001) 932-938
5. Bottner M., Unsicker K., and Suter-Crazzolara C. Expression of TGF-beta type II receptor mRNA in the CNS. NeuroReport 7 (1996) 2903-2907
6. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463 (2003) 235-272
7. Cooper J.R., Bloom F.E., and Roth R.H. The Biochemical Basis of Neuropharmacolgy. 8th edition (2003), Oxford Univ Press 196-197
8. Cooper J.R., Bloom F.E., and Roth R.H. The Biochemical Basis of Neuropharmacology (2003), Oxford Univ Press 204-205
9. Day H.E., Vittoz N.M., Oates M.M., Badiani A., Watson Jr. S.J., Robinson T.E., and Akil H. A 6-hydroxydopamine lesion of the mesostriatal dopamine system decreases the expression of corticotropin releasing hormone and neurotensin mRNAs in the amygdala and bed nucleus of the stria terminalis. Brain Res. 945 (2002) 151-159
10. Derynck R., and Feng X.H. TGF-beta receptor signaling. Biochim. Biophys. Acta 1333 (1997) F105-F150
11. Dunkley P.R., Bobrovskaya L., Graham M.E., von Nagy-Felsobuki E.I., and Dickson P.W. Tyrosine hydroxylase phosphorylation: regulation and consequences. J. Neurochem. 91 (2004) 1025-1043
12. Engelbrecht A.H., Russell V., Carstens M.E., De Villiers A.S., Searson A., Jaffer A., and Taljaard J.J. Evidence that noradrenergic neurons in the A1 and A2 nuclei are lesioned by low doses of 6-OHDA injected into the locus coeruleus. J. Neurosci. Methods 52 (1994) 57-60
13. Frayn K.N. Calculation of substrate oxidation rates in vivo from gaseous exchange. J. Appl. Physiol. 55 (1983) 628-634
14. Fujisawa H., and Okuno S. Regulatory mechanism of tyrosine hydroxylase activity. Biochem. Biophys. Res. Commun. 338 (2005) 271-276
15. Hermansen L., Hultman E., and Saltin B. Muscle glycogen during prolonged severe exercise. Acta Physiol. Scand. 71 (1967) 129-139
16. Hurley B.F., Nemeth P.M., Martin III W.H., Hagberg J.M., Dalsky G.P., and Holloszy J.O. Muscle triglyceride utilization during exercise: effect of training. J. Appl. Physiol. 60 (1986) 562-567
17. Inoue K., Yamazaki H., Manabe Y., Fukuda C., Hanai K., and Fushiki T. Transforming growth factor-beta activated during exercise in brain depresses spontaneous motor activity of animals. Relevance to central fatigue. Brain Res. 846 (1999) 145-153
18. Ishikawa T., Mizunoya W., Shibakusa T., Inoue K., and Fushiki T. Transforming growth factor-beta in the brain regulates fat metabolism during endurance exercise. Am. J. Physiol: Endocrinol. Metab. 291 (2006) E1151-E1159
19. Katafuchi T., Kondo T., Yasaka T., Kubo K., Take S., and Yoshimura M. Prolonged effects of polyriboinosinic:polyribocytidylic acid on spontaneous running wheel activity and brain interferon-alpha mRNA in rats: a model for immunologically induced fatigue. Neuroscience 120 (2003) 837-845
20. Meguid M.M., Fetissov S.O., Varma M., Sato T., Zhang L., Laviano A., and Rossi-Fanelli F. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 16 (2000) 843-857
21. Minokoshi Y., Saito M., and Shimazu T. Sympathetic denervation impairs responses of brown adipose tissue to VMH stimulation. Am. J. Physiol. 251 (1986) R1005-R1008
22. Nishizawa Y., and Bray G.A. Ventromedial hypothalamic lesions and the mobilization of fatty acids. J. Clin. Invest. 61 (1978) 714-721
23. Paxinos G., and Watson C. The Rat Brain. 5th edition (2005), Academic Press
24. Ritter S., Bugarith K., and Dinh T.T. Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation. J. Comp. Neurol. 432 (2001) 197-216
25. Ruffin M., and Nicolaidis S. Electrical stimulation of the ventromedial hypothalamus enhances both fat utilization and metabolic rate that precede and parallel the inhibition of feeding behavior. Brain Res. 846 (1999) 23-29
26. Saito M., Minokoshi Y., and Shimazu T. Ventromedial hypothalamic stimulation accelerates norepinephrine turnover in brown adipose tissue of rats. Life Sci. 41 (1987) 193-197
27. Saito M., Minokoshi Y., and Shimazu T. Accelerated norepinephrine turnover in peripheral tissues after ventromedial hypothalamic stimulation in rats. Brain Res. 481 (1989) 298-303
28. Sakaguchi T., and Bray G.A. Effect of norepinephrine, serotonin and tryptophan on the firing rate of sympathetic nerves. Brain Res. 492 (1989) 271-280
29. Scheurink A.J., Steffens A.B., and Gaykema R.P. Hypothalamic adrenoceptors mediate sympathoadrenal activity in exercising rats. Am. J. Physiol. 259 (1990) R470-R477
30. Scheurink A.J., Steffens A.B., and Gaykema R.P. Paraventricular hypothalamic adrenoceptors and energy metabolism in exercising rats. Am. J. Physiol. 259 (1990) R478-R484
31. Schwartz M.W., Woods S.C., Porte Jr. D., Seeley R.J., and Baskin D.G. Central nervous system control of food intake. Nature 404 (2000) 661-671
32. Shimazu T., and Takahashi A. Stimulation of hypothalamic nuclei has differential effects on lipid synthesis in brown and white adipose tissue. Nature 284 (1980) 62-63
33. Steffens A.B., Damsma G., van der Gugten J., and Luiten P.G. Circulating free fatty acids, insulin, and glucose during chemical stimulation of hypothalamus in rats. Am. J. Physiol. 247 (1984) E765-E771
34. Steffens A.B., Scheurink A.J., Luiten P.G., and Bohus B. Hypothalamic food intake regulating areas are involved in the homeostasis of blood glucose and plasma FFA levels. Physiol. Behav. 44 (1988) 581-589
35. Takahashi A., and Shimazu T. Hypothalamic regulation of lipid metabolism in the rat: effect of hypothalamic stimulation on lipolysis. J. Auton. Nerv. Syst. 4 (1981) 195-205
36. Tokunaga K., Fukushima M., Lupien J.R., Bray G.A., Kemnitz J.W., and Schemmel R. Effects of food restriction and adrenalectomy in rats with VMH or PVH lesions. Physiol. Behav. 45 (1989) 1131-1137
37. Toska K., Kleppe R., Armstrong C.G., Morrice N.A., Cohen ., and Haavik J. Regulation of tyrosine hydroxylase by stress-activated protein kinases. J. Neurochem. 83 (2002) 775-783
38. Uyama N., Geerts A., and Reynaert H. Neural connections between the hypothalamus and the liver. Anat. Rec. A. Discov. Mol. Cell Evol. Biol. 280 (2004) 808-820
39. Weingarten H.P., Chang P.K., and McDonald T.J. Comparison of the metabolic and behavioral disturbances following paraventricular- and ventromedial-hypothalamic lesions. Brain Res. Bull. 14 (1985) 551-559
40. Yamazaki H., Arai M., Matsumura S., Inoue K., and Fushiki T. Intracranial administration of transforming growth factor-beta3 increases fat oxidation in rats. Am. J. Physiol: Endocrinol. Metab. 283 (2002) E536-E544
41. Yasuda T., Masaki T., Sakata T., and Yoshimatsu H. Hypothalamic neuronal histamine regulates sympathetic nerve activity and expression of uncoupling protein 1 mRNA in brown adipose tissue in rats. Neuroscience 125 (2004) 535-540
42. Yoshimatsu H., Egawa M., and Bray G.A. Sympathetic nerve activity after discrete hypothalamic injections of l-glutamate. Brain Res. 601 (1993) 121-128
43. Yu L., Hebert M.C., and Zhang Y.E. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 21 (2002) 3749-3759